UNSPSC 85819421: Transfusion of nonautologous cord blood stem cells into peripheral vein, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to transfusion of nonautologous cord blood stem cells into peripheral vein, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 30230X1

UNSPSC 85819421 Transfusion of nonautologous cord blood stem cells into peripheral vein, open approach is a Commodity code that shows little relevant recent activity under its nominal scope. The six recent state and local opportunities tagged to this code—covering independent medical evaluation services for disability retirement determinations, surgical benefit carve-out programs, occupational medical surveillance, juvenile detention healthcare, pharmacy benefit management, and temporary health professional staffing—bear no meaningful connection to cord blood stem cell transfusion services. The code appears to have been applied as a catch-all medical-services classification rather than a descriptor of actual procurement in this specialized clinical domain. State and local procurement offices issuing under this code include county retirement boards (Phoenix), municipal health authorities (Long Beach), state transportation agencies (Washington State Department of Transportation), county health departments and juvenile justice systems (Harris County, Collier County), and regional health systems (Santa Clara County Health System).

No solicitations in the source material reflect procurement of cord blood stem cell transfusion services, cellular therapy products, or related biologics. The opportunities represent routine state and local health plan administration, occupational health compliance, and temporary medical staffing—commodity categories distinct from regenerative medicine procurement. Absent evidence that state and local governments are actively soliciting cord blood stem cell transfusion services, this code does not represent a meaningful market opportunity at the state and local level under its stated clinical definition.